Literature DB >> 23481567

Aging enhances classical activation but mitigates alternative activation in the central nervous system.

Daniel C Lee1, Claudia R Ruiz, Lori Lebson, Maj-Linda B Selenica, Justin Rizer, Jerry B Hunt, Rahil Rojiani, Patrick Reid, Sidharth Kammath, Kevin Nash, Chad A Dickey, Marcia Gordon, Dave Morgan.   

Abstract

The roles of microglia and macrophages during neuroinflammation and neurodegenerative diseases remain controversial. To date, at least 2 activations states have been suggested, consisting of a classical response (M1) and the alternative response (M2). Identifying selective biomarkers of microglia that representative their functional activation states may help elucidate disease course and enable a better understanding of repair mechanisms. Two cocktails containing either tumor necrosis factor (TNF)-α, interleukin (IL)-12, and IL-1β (referred to as CKT-1) or IL-13 and IL-4 (referred to CKT-2) were injections into the hippocampus of mice aged 6, 12, or 24 months. Microarray analysis was performed on hippocampal tissue 3 days postinjection. Gene transcripts were compared between CKT-1 versus CKT-2 stimulator cocktails. Several selective transcripts expressed for the CKT-1 included CXCL13, haptoglobin, MARCO, and calgranulin B, whereas a smaller subset of genes was selectively induced by the CKT-2 and consisted of FIZZ1, IGF-1, and EAR 11. Importantly, selective transcripts were induced at all ages by CKT-1, whereas selective gene transcripts induced by CKT-2 decreased with age suggesting an age-related reduction in the IL-4/ IL-13 signaling pathway.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23481567      PMCID: PMC3652232          DOI: 10.1016/j.neurobiolaging.2012.12.014

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  32 in total

Review 1.  Alternative activation of macrophages.

Authors:  Siamon Gordon
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

Review 2.  Heterogeneity of CNS myeloid cells and their roles in neurodegeneration.

Authors:  Marco Prinz; Josef Priller; Sangram S Sisodia; Richard M Ransohoff
Journal:  Nat Neurosci       Date:  2011-09-27       Impact factor: 24.884

3.  Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice.

Authors:  G DiCarlo; D Wilcock; D Henderson; M Gordon; D Morgan
Journal:  Neurobiol Aging       Date:  2001 Nov-Dec       Impact factor: 4.673

4.  Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.

Authors:  Marcia N Gordon; Leigh A Holcomb; Paul T Jantzen; Giovanni DiCarlo; Donna Wilcock; Kristal W Boyett; Karen Connor; Jason Melachrino; James P O'Callaghan; Dave Morgan
Journal:  Exp Neurol       Date:  2002-02       Impact factor: 5.330

Review 5.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

6.  Erythroid differentiation regulator 1, an interleukin 18-regulated gene, acts as a metastasis suppressor in melanoma.

Authors:  Min Kyung Jung; Yoorim Park; Seok Bean Song; So Young Cheon; Sunyoung Park; Younkyung Houh; Soogyeong Ha; Hee Jung Kim; Jung Min Park; Tae Sung Kim; Wang Jae Lee; Byung Joo Cho; Sa Ik Bang; Hyunjeong Park; Daeho Cho
Journal:  J Invest Dermatol       Date:  2011-06-23       Impact factor: 8.551

7.  Analysis of mannose receptor regulation by IL-4, IL-10, and proteolytic processing using novel monoclonal antibodies.

Authors:  Luisa Martinez-Pomares; Delyth M Reid; Gordon D Brown; Philip R Taylor; Richard J Stillion; Sheena A Linehan; Susanne Zamze; Siamon Gordon; Simon Y C Wong
Journal:  J Leukoc Biol       Date:  2003-05       Impact factor: 4.962

8.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

9.  Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.

Authors:  Paul S Aisen; Kimberly A Schafer; Michael Grundman; Eric Pfeiffer; Mary Sano; Kenneth L Davis; Martin R Farlow; Shelia Jin; Ronald G Thomas; Leon J Thal
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

Review 10.  The inflammatory macrophage: a story of Jekyll and Hyde.

Authors:  Jeremy S Duffield
Journal:  Clin Sci (Lond)       Date:  2003-01       Impact factor: 6.124

View more
  61 in total

Review 1.  Glia-immune interactions post-ischemic stroke and potential therapies.

Authors:  Jessica Hersh; Shao-Hua Yang
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-11

2.  Redox regulation of NF-κB p50 and M1 polarization in microglia.

Authors:  Thomas Taetzsch; Shannon Levesque; Constance McGraw; Savannah Brookins; Rafy Luqa; Marcelo G Bonini; Ronald P Mason; Unsong Oh; Michelle L Block
Journal:  Glia       Date:  2014-10-21       Impact factor: 7.452

Review 3.  Targeting innate immunity for neurodegenerative disorders of the central nervous system.

Authors:  Katrin I Andreasson; Adam D Bachstetter; Marco Colonna; Florent Ginhoux; Clive Holmes; Bruce Lamb; Gary Landreth; Daniel C Lee; Donovan Low; Marina A Lynch; Alon Monsonego; M Kerry O'Banion; Milos Pekny; Till Puschmann; Niva Russek-Blum; Leslie A Sandusky; Maj-Linda B Selenica; Kazuyuki Takata; Jessica Teeling; Terrence Town; Linda J Van Eldik
Journal:  J Neurochem       Date:  2016-09       Impact factor: 5.372

Review 4.  Microglial dysfunction in brain aging and Alzheimer's disease.

Authors:  Kira Irving Mosher; Tony Wyss-Coray
Journal:  Biochem Pharmacol       Date:  2014-01-18       Impact factor: 5.858

Review 5.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

Review 6.  Partial MHC class II constructs as novel immunomodulatory therapy for stroke.

Authors:  Gil Benedek; Arthur A Vandenbark; Nabil J Alkayed; Halina Offner
Journal:  Neurochem Int       Date:  2016-10-31       Impact factor: 3.921

Review 7.  Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases.

Authors:  Paula C Bickford; Antwoine Flowers; Bethany Grimmig
Journal:  Exp Gerontol       Date:  2017-02-02       Impact factor: 4.032

Review 8.  Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases.

Authors:  Yu Tang; Weidong Le
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

9.  IL-4 signaling drives a unique arginase+/IL-1β+ microglia phenotype and recruits macrophages to the inflammatory CNS: consequences of age-related deficits in IL-4Rα after traumatic spinal cord injury.

Authors:  Ashley M Fenn; Jodie C E Hall; John C Gensel; Phillip G Popovich; Jonathan P Godbout
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

Review 10.  Stroke neuroprotection: oestrogen and insulin-like growth factor-1 interactions and the role of microglia.

Authors:  F Sohrabji; M Williams
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.